An Open-Labelled, Randomized Phase II Study in Patients with Recurrent Glioblastoma Multiforme Comparing Progression Free Survival of Alecsat (Autologous Lymphoid Effector Cells Specific Against Tumour-Cells) Versus Bevacizumab/irinotecan

C. Haslund, A. Muhic, S. Lukacova, B. Lund, Y. Lassen-Ramshad, Mette Meyer, M. Roland, Hans Skovgaard Poulsen

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
JournalNeuro-Oncology
Volume18
Pages (from-to)iv6
Number of pages1
ISSN1522-8517
DOIs
Publication statusPublished - 1 Oct 2016
EventEANO 2016 Meeting - Mannheim, Germany
Duration: 12 Oct 201616 Oct 2016
Conference number: 12
https://www.eano.eu/eano2016/welcome/

Conference

ConferenceEANO 2016 Meeting
Number12
CountryGermany
CityMannheim
Period12/10/201616/10/2016
Internet address

Cite this